ACADIA Pharmaceuticals Inc. (ACAD)

NASDAQ: ACAD · Real-Time Price · USD

Compare

22.95

+0.92 (4.18%)

At close: Feb 17, 2026, 4:00 PM EST

23.35

+0.40 (1.74%)

After-hours: Feb 17, 2026, 7:05 PM EST

ACADIA Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,047	957.8	726.44	517.24	484.15	441.76
Revenue Growth (YoY)	12.69%	31.85%	40.45%	6.83%	9.60%	30.28%
Cost of Revenue	429.35	385.09	393.26	371.74	258.56	286.88
Gross Profit	617.77	572.71	333.18	145.49	225.59	154.88
Selling, General & Admin	523.36	488.43	406.56	369.09	396.03	388.66
Operating Expenses	523.36	488.43	406.56	369.09	396.03	388.66
Operating Income	94.41	84.28	-73.38	-223.6	-170.44	-233.79
Interest & Investment Income	30.4	25.46	17.23	6.61	0.59	6.61
Other Non Operating Income (Expenses)	2.35	1.82	-	-	-	-
EBT Excluding Unusual Items	127.16	111.56	-56.15	-216.99	-169.85	-227.18
Merger & Restructuring Charges	-	-	-	-	-	-52.8
Gain (Loss) on Sale of Investments	-	-	5.11	3.54	2.33	-1
Gain (Loss) on Sale of Assets	146.52	146.52	-	-	-	-
Pretax Income	273.67	258.08	-51.04	-213.44	-167.52	-280.97
Income Tax Expense	12.5	31.62	10.25	2.53	0.35	0.61
Net Income	261.17	226.45	-61.29	-215.98	-167.87	-281.58
Net Income to Common	261.17	226.45	-61.29	-215.98	-167.87	-281.58
Shares Outstanding (Basic)	168	166	164	162	160	157
Shares Outstanding (Diluted)	169	166	164	162	160	157
Shares Change (YoY)	1.70%	1.55%	1.32%	0.74%	2.01%	6.88%
EPS (Basic)	1.56	1.37	-0.37	-1.34	-1.05	-1.79
EPS (Diluted)	1.54	1.36	-0.37	-1.34	-1.05	-1.79
Free Cash Flow	197.81	157.2	16.65	-114.04	-126.78	-143.75
Free Cash Flow Per Share	1.17	0.94	0.10	-0.70	-0.79	-0.91
Gross Margin	59.00%	59.79%	45.87%	28.13%	46.59%	35.06%
Operating Margin	9.02%	8.80%	-10.10%	-43.23%	-35.20%	-52.92%
Profit Margin	24.94%	23.64%	-8.44%	-41.76%	-34.67%	-63.74%
Free Cash Flow Margin	18.89%	16.41%	2.29%	-22.05%	-26.19%	-32.54%
EBITDA	108.46	100.16	-67.83	-221.57	-167.1	-230.85
EBITDA Margin	10.36%	10.46%	-9.34%	-42.84%	-34.51%	-52.26%
D&A For EBITDA	14.05	15.88	5.55	2.03	3.34	2.93
EBIT	94.41	84.28	-73.38	-223.6	-170.44	-233.79
EBIT Margin	9.02%	8.80%	-10.10%	-43.23%	-35.20%	-52.92%
Effective Tax Rate	4.57%	12.25%	-	-	-	-
Revenue as Reported	1,047	957.8	726.44	517.24	484.15	441.76
Advertising Expenses	-	21.1	9.4	5.5	41.8	51.1

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q